HF
SUPN icon

HRT Financial’s Supernus Pharmaceuticals SUPN Stock Holding History

HRT Financial’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-29,510
Closed -$1.47M – 4690
2025
Q4 		$1.47M Sell
29,510
-62,350
-68% -$3.03M ﹤0.01% 1500
2025
Q3 		$4.39M Buy
+91,860
New +$3.7M 0.02% 730
2025
Q2 		– Sell
-74,491
Closed -$2.44M – 3489
2025
Q1 		$2.44M Buy
+74,491
New +$2.64M 0.02% 730
2023
Q4 		– Sell
-56,739
Closed -$1.56M – 3044
2023
Q3 		$1.56M Buy
56,739
+35,145
+163% +$1.07M 0.02% 732
2023
Q2 		$649K Sell
21,594
-27,870
-56% -$975K 0.01% 1216
2023
Q1 		$1.79M Buy
49,464
+18,183
+58% +$699K 0.02% 651
2022
Q4 		$1.11M Sell
31,281
-21,317
-41% -$741K 0.02% 892
2022
Q3 		$1.78M Buy
52,598
+40,757
+344% +$1.33M 0.02% 651
2022
Q2 		$342K Buy
+11,841
New +$339K ﹤0.01% 1932
2022
Q1 		– Sell
-80,576
Closed -$2.35M – 3830
2021
Q4 		$2.35M Buy
80,576
+59,202
+277% +$1.8M 0.01% 583
2021
Q3 		$570K Buy
+21,374
New +$574K ﹤0.01% 1861
2020
Q3 		– Sell
-14,282
Closed -$339K – 2321
2020
Q2 		$339K Buy
+14,282
New +$316K 0.01% 938

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial's SUPN Position: Q1 2026 in Review

HRT Financial sold out of Supernus Pharmaceuticals (SUPN) in Q1 2026, closing a stake of 29,510 shares — an estimated $1.47M sold.

HRT Financial first reported a position in SUPN in Q2 2020 and held it in 12 quarters. The position peaked at $4.39M in Q3 2025. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • HRT Financial reported no remaining Supernus Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 29,510 Supernus Pharmaceuticals shares in Q1 2026, an estimated $1.47M.
  • HRT Financial first reported a position in Supernus Pharmaceuticals in Q2 2020 and held it in 12 quarters.
  • HRT Financial's Supernus Pharmaceuticals position peaked at $4.39M in Q3 2025.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.